Azure Biotech, Inc. — Form D
Azure Biotech, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-06. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-05-06
- Form: D
- Accession: 0001630005-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.7M
- Amount sold: $2.7M
- Investors: 78
- Date of first sale: 2021-12-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-444806
Issuer
- Name: Azure Biotech, Inc.
- CIK: 0001630005
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 500 East 85th Street, New York, NY, 10025
- Phone: 917-747-9591
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Valerie Ceva | Director | Morristown, NJ |
| Susan Levinson | Director | Morristown, NJ |
| Valerie Ceva | Executive Officer | Morristown, NJ |
| Steven R Goldstein | Director | New York, NY |
| Susan A Levinson | Director | Portland, OR |
| Ralph Makar | Executive Officer | Portland, OR |
| David D Thompson | Director | Portland, OR |
| Valerie A Ceva | Director | Portland, OR |
| Valerie A Ceva | Executive Officer | Portland, OR |
Other filings by this issuer (1)
More